nodes	percent_of_prediction	percent_of_DWPC	metapath
Asenapine—HTR1D—meninx—sarcoma	0.0512	0.154	CbGeAlD
Asenapine—HTR1B—dura mater—sarcoma	0.0487	0.147	CbGeAlD
Asenapine—HTR1D—dura mater—sarcoma	0.0472	0.142	CbGeAlD
Asenapine—CYP1A2—Dacarbazine—sarcoma	0.0425	0.261	CbGbCtD
Asenapine—CYP3A4—Thiotepa—sarcoma	0.0402	0.247	CbGbCtD
Asenapine—CYP1A2—Etoposide—sarcoma	0.0208	0.128	CbGbCtD
Asenapine—CYP3A4—Mitoxantrone—sarcoma	0.0173	0.106	CbGbCtD
Asenapine—HTR7—pulmonary artery—sarcoma	0.016	0.0482	CbGeAlD
Asenapine—CYP3A4—Vincristine—sarcoma	0.0119	0.0731	CbGbCtD
Asenapine—CYP2D6—Doxorubicin—sarcoma	0.0117	0.0718	CbGbCtD
Asenapine—CYP3A4—Etoposide—sarcoma	0.0109	0.067	CbGbCtD
Asenapine—HTR2A—pulmonary artery—sarcoma	0.01	0.0301	CbGeAlD
Asenapine—HTR1E—myometrium—sarcoma	0.00788	0.0237	CbGeAlD
Asenapine—UGT1A4—hematopoietic system—sarcoma	0.00774	0.0233	CbGeAlD
Asenapine—CYP3A4—Doxorubicin—sarcoma	0.00744	0.0457	CbGbCtD
Asenapine—HTR2A—hindlimb—sarcoma	0.00605	0.0182	CbGeAlD
Asenapine—HTR2A—appendage—sarcoma	0.00519	0.0156	CbGeAlD
Asenapine—HTR7—endothelium—sarcoma	0.00502	0.0151	CbGeAlD
Asenapine—HRH2—hematopoietic system—sarcoma	0.00485	0.0146	CbGeAlD
Asenapine—DRD4—testis—sarcoma	0.0043	0.0129	CbGeAlD
Asenapine—HRH2—skin of body—sarcoma	0.00422	0.0127	CbGeAlD
Asenapine—UGT1A4—liver—sarcoma	0.00401	0.0121	CbGeAlD
Asenapine—HRH2—cardiac atrium—sarcoma	0.00368	0.0111	CbGeAlD
Asenapine—HTR2B—myometrium—sarcoma	0.00335	0.0101	CbGeAlD
Asenapine—HTR2A—endothelium—sarcoma	0.00313	0.00942	CbGeAlD
Asenapine—HTR1D—connective tissue—sarcoma	0.00298	0.00897	CbGeAlD
Asenapine—SLC6A4—hematopoietic system—sarcoma	0.00291	0.00874	CbGeAlD
Asenapine—ADRB1—connective tissue—sarcoma	0.0029	0.00872	CbGeAlD
Asenapine—ADRA2C—myometrium—sarcoma	0.00264	0.00794	CbGeAlD
Asenapine—HTR1A—hematopoietic system—sarcoma	0.00258	0.00776	CbGeAlD
Asenapine—HTR2B—smooth muscle tissue—sarcoma	0.00254	0.00763	CbGeAlD
Asenapine—HRH2—liver—sarcoma	0.00251	0.00756	CbGeAlD
Asenapine—HTR2B—skin of body—sarcoma	0.0025	0.00753	CbGeAlD
Asenapine—HTR7—hematopoietic system—sarcoma	0.00247	0.00742	CbGeAlD
Asenapine—ADRA2C—seminal vesicle—sarcoma	0.00239	0.00718	CbGeAlD
Asenapine—ADRA1A—hematopoietic system—sarcoma	0.00238	0.00716	CbGeAlD
Asenapine—HTR7—connective tissue—sarcoma	0.00237	0.00714	CbGeAlD
Asenapine—ADRB1—cardiac atrium—sarcoma	0.00228	0.00687	CbGeAlD
Asenapine—HTR2B—uterus—sarcoma	0.00218	0.00654	CbGeAlD
Asenapine—HTR7—smooth muscle tissue—sarcoma	0.00217	0.00654	CbGeAlD
Asenapine—HRH1—myometrium—sarcoma	0.00214	0.00645	CbGeAlD
Asenapine—ADRA2A—myometrium—sarcoma	0.00211	0.00634	CbGeAlD
Asenapine—CYP1A2—hematopoietic system—sarcoma	0.00197	0.00592	CbGeAlD
Asenapine—HRH2—lymph node—sarcoma	0.00193	0.0058	CbGeAlD
Asenapine—HTR2B—tendon—sarcoma	0.00191	0.00573	CbGeAlD
Asenapine—ADRA2A—seminal vesicle—sarcoma	0.0019	0.00573	CbGeAlD
Asenapine—HRH1—hematopoietic system—sarcoma	0.00184	0.00554	CbGeAlD
Asenapine—Agitation—Thiotepa—sarcoma	0.00184	0.00382	CcSEcCtD
Asenapine—Mediastinal disorder—Vincristine—sarcoma	0.00184	0.00382	CcSEcCtD
Asenapine—Anaemia—Dactinomycin—sarcoma	0.00184	0.00382	CcSEcCtD
Asenapine—Dyskinesia—Doxorubicin—sarcoma	0.00182	0.00377	CcSEcCtD
Asenapine—ADRA2A—hematopoietic system—sarcoma	0.00181	0.00544	CbGeAlD
Asenapine—Dysarthria—Doxorubicin—sarcoma	0.0018	0.00375	CcSEcCtD
Asenapine—Ulcer—Doxorubicin—sarcoma	0.0018	0.00375	CcSEcCtD
Asenapine—Stomatitis—Etoposide—sarcoma	0.00179	0.00373	CcSEcCtD
Asenapine—Leukopenia—Thiotepa—sarcoma	0.00179	0.00372	CcSEcCtD
Asenapine—Malaise—Dactinomycin—sarcoma	0.00179	0.00372	CcSEcCtD
Asenapine—Salivary hypersecretion—Epirubicin—sarcoma	0.00179	0.00372	CcSEcCtD
Asenapine—Mental disorder—Vincristine—sarcoma	0.00179	0.00371	CcSEcCtD
Asenapine—Leukopenia—Dactinomycin—sarcoma	0.00178	0.0037	CcSEcCtD
Asenapine—HRH1—connective tissue—sarcoma	0.00177	0.00533	CbGeAlD
Asenapine—Skin exfoliation—Epirubicin—sarcoma	0.00176	0.00366	CcSEcCtD
Asenapine—Inflammation—Doxorubicin—sarcoma	0.00176	0.00366	CcSEcCtD
Asenapine—ADRA2A—connective tissue—sarcoma	0.00174	0.00524	CbGeAlD
Asenapine—Hepatobiliary disease—Etoposide—sarcoma	0.00174	0.00362	CcSEcCtD
Asenapine—Convulsion—Thiotepa—sarcoma	0.00173	0.0036	CcSEcCtD
Asenapine—Hypertension—Thiotepa—sarcoma	0.00173	0.00359	CcSEcCtD
Asenapine—HTR2A—embryo—sarcoma	0.00172	0.00518	CbGeAlD
Asenapine—ADRA2C—cardiac atrium—sarcoma	0.00172	0.00518	CbGeAlD
Asenapine—Agranulocytosis—Etoposide—sarcoma	0.00172	0.00357	CcSEcCtD
Asenapine—ADRA2C—uterus—sarcoma	0.00171	0.00515	CbGeAlD
Asenapine—Pulmonary embolism—Doxorubicin—sarcoma	0.00171	0.00355	CcSEcCtD
Asenapine—Arthralgia—Thiotepa—sarcoma	0.0017	0.00354	CcSEcCtD
Asenapine—Anxiety—Thiotepa—sarcoma	0.0017	0.00353	CcSEcCtD
Asenapine—Dysgeusia—Mitoxantrone—sarcoma	0.00169	0.00352	CcSEcCtD
Asenapine—ADRA1A—lymphoid tissue—sarcoma	0.00167	0.00504	CbGeAlD
Asenapine—Mouth ulceration—Epirubicin—sarcoma	0.00167	0.00346	CcSEcCtD
Asenapine—Salivary hypersecretion—Doxorubicin—sarcoma	0.00166	0.00344	CcSEcCtD
Asenapine—Anaemia—Vincristine—sarcoma	0.00164	0.00341	CcSEcCtD
Asenapine—HTR7—tendon—sarcoma	0.00163	0.00491	CbGeAlD
Asenapine—Agitation—Vincristine—sarcoma	0.00163	0.00339	CcSEcCtD
Asenapine—Skin exfoliation—Doxorubicin—sarcoma	0.00163	0.00338	CcSEcCtD
Asenapine—HRH1—smooth muscle tissue—sarcoma	0.00162	0.00488	CbGeAlD
Asenapine—Nervous system disorder—Thiotepa—sarcoma	0.0016	0.00333	CcSEcCtD
Asenapine—Thrombocytopenia—Thiotepa—sarcoma	0.0016	0.00332	CcSEcCtD
Asenapine—Anaemia—Mitoxantrone—sarcoma	0.0016	0.00332	CcSEcCtD
Asenapine—Tachycardia—Thiotepa—sarcoma	0.00159	0.00331	CcSEcCtD
Asenapine—Leukopenia—Vincristine—sarcoma	0.00159	0.0033	CcSEcCtD
Asenapine—Thrombocytopenia—Dactinomycin—sarcoma	0.00159	0.0033	CcSEcCtD
Asenapine—Malaise—Mitoxantrone—sarcoma	0.00156	0.00324	CcSEcCtD
Asenapine—Leukopenia—Mitoxantrone—sarcoma	0.00155	0.00322	CcSEcCtD
Asenapine—Eye disorder—Etoposide—sarcoma	0.00154	0.00321	CcSEcCtD
Asenapine—Mouth ulceration—Doxorubicin—sarcoma	0.00154	0.00321	CcSEcCtD
Asenapine—Diabetes mellitus—Epirubicin—sarcoma	0.00154	0.0032	CcSEcCtD
Asenapine—HTR2A—hematopoietic system—sarcoma	0.00154	0.00463	CbGeAlD
Asenapine—Convulsion—Vincristine—sarcoma	0.00154	0.0032	CcSEcCtD
Asenapine—Cardiac disorder—Etoposide—sarcoma	0.00153	0.00319	CcSEcCtD
Asenapine—Hypertension—Vincristine—sarcoma	0.00153	0.00318	CcSEcCtD
Asenapine—ADRA2C—tendon—sarcoma	0.0015	0.00451	CbGeAlD
Asenapine—Angiopathy—Etoposide—sarcoma	0.0015	0.00311	CcSEcCtD
Asenapine—Convulsion—Mitoxantrone—sarcoma	0.0015	0.00311	CcSEcCtD
Asenapine—Hypertension—Mitoxantrone—sarcoma	0.00149	0.0031	CcSEcCtD
Asenapine—Immune system disorder—Etoposide—sarcoma	0.00149	0.0031	CcSEcCtD
Asenapine—Mediastinal disorder—Etoposide—sarcoma	0.00149	0.00309	CcSEcCtD
Asenapine—Musculoskeletal discomfort—Thiotepa—sarcoma	0.00149	0.00309	CcSEcCtD
Asenapine—HTR2A—connective tissue—sarcoma	0.00148	0.00446	CbGeAlD
Asenapine—Musculoskeletal discomfort—Dactinomycin—sarcoma	0.00148	0.00307	CcSEcCtD
Asenapine—Arthralgia—Mitoxantrone—sarcoma	0.00147	0.00306	CcSEcCtD
Asenapine—Anxiety—Mitoxantrone—sarcoma	0.00147	0.00305	CcSEcCtD
Asenapine—Somnolence—Thiotepa—sarcoma	0.00145	0.00302	CcSEcCtD
Asenapine—Anaphylactic shock—Vincristine—sarcoma	0.00145	0.00301	CcSEcCtD
Asenapine—Dyspepsia—Thiotepa—sarcoma	0.00144	0.00299	CcSEcCtD
Asenapine—Increased appetite—Epirubicin—sarcoma	0.00142	0.00296	CcSEcCtD
Asenapine—CYP3A4—hematopoietic system—sarcoma	0.00142	0.00428	CbGeAlD
Asenapine—Diabetes mellitus—Doxorubicin—sarcoma	0.00142	0.00296	CcSEcCtD
Asenapine—Nervous system disorder—Vincristine—sarcoma	0.00142	0.00295	CcSEcCtD
Asenapine—Thrombocytopenia—Vincristine—sarcoma	0.00142	0.00295	CcSEcCtD
Asenapine—Anaphylactic shock—Mitoxantrone—sarcoma	0.00141	0.00293	CcSEcCtD
Asenapine—Gastrointestinal disorder—Thiotepa—sarcoma	0.00141	0.00293	CcSEcCtD
Asenapine—Fatigue—Thiotepa—sarcoma	0.00141	0.00293	CcSEcCtD
Asenapine—Dysgeusia—Etoposide—sarcoma	0.00141	0.00293	CcSEcCtD
Asenapine—CYP2D6—hematopoietic system—sarcoma	0.0014	0.00422	CbGeAlD
Asenapine—Dermatitis bullous—Epirubicin—sarcoma	0.0014	0.00291	CcSEcCtD
Asenapine—Fatigue—Dactinomycin—sarcoma	0.0014	0.00291	CcSEcCtD
Asenapine—Constipation—Thiotepa—sarcoma	0.0014	0.0029	CcSEcCtD
Asenapine—Shock—Mitoxantrone—sarcoma	0.00139	0.00288	CcSEcCtD
Asenapine—Anaphylactoid reaction—Epirubicin—sarcoma	0.00138	0.00287	CcSEcCtD
Asenapine—Muscle spasms—Etoposide—sarcoma	0.00138	0.00287	CcSEcCtD
Asenapine—Thrombocytopenia—Mitoxantrone—sarcoma	0.00138	0.00287	CcSEcCtD
Asenapine—Tachycardia—Mitoxantrone—sarcoma	0.00138	0.00286	CcSEcCtD
Asenapine—ADRA2A—cardiac atrium—sarcoma	0.00137	0.00413	CbGeAlD
Asenapine—ADRA2A—uterus—sarcoma	0.00137	0.00411	CbGeAlD
Asenapine—HTR2A—smooth muscle tissue—sarcoma	0.00135	0.00408	CbGeAlD
Asenapine—Hypotension—Vincristine—sarcoma	0.00135	0.00281	CcSEcCtD
Asenapine—HTR7—testis—sarcoma	0.00135	0.00407	CbGeAlD
Asenapine—Hyponatraemia—Epirubicin—sarcoma	0.00134	0.00279	CcSEcCtD
Asenapine—Osteoarthritis—Epirubicin—sarcoma	0.00134	0.00278	CcSEcCtD
Asenapine—Pain in extremity—Epirubicin—sarcoma	0.00134	0.00278	CcSEcCtD
Asenapine—Anaemia—Etoposide—sarcoma	0.00133	0.00276	CcSEcCtD
Asenapine—Musculoskeletal discomfort—Vincristine—sarcoma	0.00132	0.00274	CcSEcCtD
Asenapine—Hypotension—Mitoxantrone—sarcoma	0.00132	0.00274	CcSEcCtD
Asenapine—Increased appetite—Doxorubicin—sarcoma	0.00132	0.00274	CcSEcCtD
Asenapine—Insomnia—Vincristine—sarcoma	0.00131	0.00272	CcSEcCtD
Asenapine—Malaise—Etoposide—sarcoma	0.0013	0.00269	CcSEcCtD
Asenapine—Dermatitis bullous—Doxorubicin—sarcoma	0.0013	0.00269	CcSEcCtD
Asenapine—Leukopenia—Etoposide—sarcoma	0.00129	0.00267	CcSEcCtD
Asenapine—Musculoskeletal discomfort—Mitoxantrone—sarcoma	0.00129	0.00267	CcSEcCtD
Asenapine—Anaphylactoid reaction—Doxorubicin—sarcoma	0.00128	0.00266	CcSEcCtD
Asenapine—DRD2—testis—sarcoma	0.00128	0.00384	CbGeAlD
Asenapine—HTR7—liver—sarcoma	0.00128	0.00384	CbGeAlD
Asenapine—Loss of consciousness—Etoposide—sarcoma	0.00126	0.00263	CcSEcCtD
Asenapine—Dyspnoea—Mitoxantrone—sarcoma	0.00126	0.00261	CcSEcCtD
Asenapine—Somnolence—Mitoxantrone—sarcoma	0.00125	0.00261	CcSEcCtD
Asenapine—Gastrointestinal disorder—Vincristine—sarcoma	0.00125	0.0026	CcSEcCtD
Asenapine—Fatigue—Vincristine—sarcoma	0.00125	0.0026	CcSEcCtD
Asenapine—Convulsion—Etoposide—sarcoma	0.00125	0.00259	CcSEcCtD
Asenapine—Hyponatraemia—Doxorubicin—sarcoma	0.00124	0.00258	CcSEcCtD
Asenapine—ADRA2C—testis—sarcoma	0.00124	0.00374	CbGeAlD
Asenapine—Dyspepsia—Mitoxantrone—sarcoma	0.00124	0.00258	CcSEcCtD
Asenapine—Hypertension—Etoposide—sarcoma	0.00124	0.00258	CcSEcCtD
Asenapine—Constipation—Vincristine—sarcoma	0.00124	0.00257	CcSEcCtD
Asenapine—Pain in extremity—Doxorubicin—sarcoma	0.00124	0.00257	CcSEcCtD
Asenapine—Osteoarthritis—Doxorubicin—sarcoma	0.00124	0.00257	CcSEcCtD
Asenapine—ADRA1A—liver—sarcoma	0.00123	0.00371	CbGeAlD
Asenapine—Orthostatic hypotension—Epirubicin—sarcoma	0.00122	0.00254	CcSEcCtD
Asenapine—HRH1—tendon—sarcoma	0.00122	0.00367	CbGeAlD
Asenapine—Fatigue—Mitoxantrone—sarcoma	0.00122	0.00253	CcSEcCtD
Asenapine—Breast disorder—Epirubicin—sarcoma	0.00121	0.00251	CcSEcCtD
Asenapine—Constipation—Mitoxantrone—sarcoma	0.00121	0.00251	CcSEcCtD
Asenapine—Hypersensitivity—Thiotepa—sarcoma	0.0012	0.0025	CcSEcCtD
Asenapine—ADRA2A—tendon—sarcoma	0.0012	0.0036	CbGeAlD
Asenapine—Hypersensitivity—Dactinomycin—sarcoma	0.00119	0.00248	CcSEcCtD
Asenapine—Alanine aminotransferase increased—Epirubicin—sarcoma	0.00118	0.00245	CcSEcCtD
Asenapine—ADRA2C—liver—sarcoma	0.00117	0.00353	CbGeAlD
Asenapine—Anaphylactic shock—Etoposide—sarcoma	0.00117	0.00244	CcSEcCtD
Asenapine—Asthenia—Thiotepa—sarcoma	0.00117	0.00244	CcSEcCtD
Asenapine—Asthenia—Dactinomycin—sarcoma	0.00116	0.00242	CcSEcCtD
Asenapine—Dysphagia—Epirubicin—sarcoma	0.00116	0.0024	CcSEcCtD
Asenapine—Thrombocytopenia—Etoposide—sarcoma	0.00115	0.00239	CcSEcCtD
Asenapine—Tachycardia—Etoposide—sarcoma	0.00115	0.00238	CcSEcCtD
Asenapine—HTR2B—lymph node—sarcoma	0.00114	0.00344	CbGeAlD
Asenapine—Orthostatic hypotension—Doxorubicin—sarcoma	0.00113	0.00235	CcSEcCtD
Asenapine—Breast disorder—Doxorubicin—sarcoma	0.00112	0.00233	CcSEcCtD
Asenapine—Hypotension—Etoposide—sarcoma	0.0011	0.00228	CcSEcCtD
Asenapine—Alanine aminotransferase increased—Doxorubicin—sarcoma	0.00109	0.00227	CcSEcCtD
Asenapine—Neutropenia—Epirubicin—sarcoma	0.00108	0.00225	CcSEcCtD
Asenapine—Dizziness—Thiotepa—sarcoma	0.00108	0.00225	CcSEcCtD
Asenapine—Dysphagia—Doxorubicin—sarcoma	0.00107	0.00222	CcSEcCtD
Asenapine—Hypersensitivity—Vincristine—sarcoma	0.00107	0.00222	CcSEcCtD
Asenapine—Weight increased—Epirubicin—sarcoma	0.00105	0.00219	CcSEcCtD
Asenapine—Dyspnoea—Etoposide—sarcoma	0.00105	0.00217	CcSEcCtD
Asenapine—Hyperglycaemia—Epirubicin—sarcoma	0.00104	0.00217	CcSEcCtD
Asenapine—Somnolence—Etoposide—sarcoma	0.00104	0.00217	CcSEcCtD
Asenapine—Hypersensitivity—Mitoxantrone—sarcoma	0.00104	0.00216	CcSEcCtD
Asenapine—Asthenia—Vincristine—sarcoma	0.00104	0.00216	CcSEcCtD
Asenapine—Vomiting—Thiotepa—sarcoma	0.00104	0.00216	CcSEcCtD
Asenapine—Vomiting—Dactinomycin—sarcoma	0.00103	0.00214	CcSEcCtD
Asenapine—Rash—Thiotepa—sarcoma	0.00103	0.00214	CcSEcCtD
Asenapine—Dermatitis—Thiotepa—sarcoma	0.00103	0.00214	CcSEcCtD
Asenapine—Headache—Thiotepa—sarcoma	0.00102	0.00213	CcSEcCtD
Asenapine—Rash—Dactinomycin—sarcoma	0.00102	0.00212	CcSEcCtD
Asenapine—CYP1A2—liver—sarcoma	0.00102	0.00307	CbGeAlD
Asenapine—HTR2A—tendon—sarcoma	0.00102	0.00306	CbGeAlD
Asenapine—Gastrointestinal disorder—Etoposide—sarcoma	0.00101	0.00211	CcSEcCtD
Asenapine—Asthenia—Mitoxantrone—sarcoma	0.00101	0.0021	CcSEcCtD
Asenapine—Fatigue—Etoposide—sarcoma	0.00101	0.0021	CcSEcCtD
Asenapine—HRH1—testis—sarcoma	0.00101	0.00304	CbGeAlD
Asenapine—Stomatitis—Epirubicin—sarcoma	0.00101	0.00209	CcSEcCtD
Asenapine—Constipation—Etoposide—sarcoma	0.001	0.00209	CcSEcCtD
Asenapine—Neutropenia—Doxorubicin—sarcoma	0.001	0.00208	CcSEcCtD
Asenapine—ADRA2A—testis—sarcoma	0.000991	0.00298	CbGeAlD
Asenapine—Hepatobiliary disease—Epirubicin—sarcoma	0.000976	0.00203	CcSEcCtD
Asenapine—Weight increased—Doxorubicin—sarcoma	0.000974	0.00202	CcSEcCtD
Asenapine—Nausea—Thiotepa—sarcoma	0.00097	0.00202	CcSEcCtD
Asenapine—Hyperglycaemia—Doxorubicin—sarcoma	0.000966	0.00201	CcSEcCtD
Asenapine—Nausea—Dactinomycin—sarcoma	0.000963	0.002	CcSEcCtD
Asenapine—Agranulocytosis—Epirubicin—sarcoma	0.000963	0.002	CcSEcCtD
Asenapine—Dizziness—Vincristine—sarcoma	0.000958	0.00199	CcSEcCtD
Asenapine—Stomatitis—Doxorubicin—sarcoma	0.00093	0.00193	CcSEcCtD
Asenapine—Vomiting—Vincristine—sarcoma	0.000921	0.00191	CcSEcCtD
Asenapine—Rash—Vincristine—sarcoma	0.000913	0.0019	CcSEcCtD
Asenapine—Dermatitis—Vincristine—sarcoma	0.000913	0.0019	CcSEcCtD
Asenapine—Oedema peripheral—Epirubicin—sarcoma	0.000912	0.0019	CcSEcCtD
Asenapine—Connective tissue disorder—Epirubicin—sarcoma	0.00091	0.00189	CcSEcCtD
Asenapine—Headache—Vincristine—sarcoma	0.000908	0.00189	CcSEcCtD
Asenapine—Hepatobiliary disease—Doxorubicin—sarcoma	0.000903	0.00188	CcSEcCtD
Asenapine—ADRA2C—lymph node—sarcoma	0.000901	0.00271	CbGeAlD
Asenapine—Vomiting—Mitoxantrone—sarcoma	0.000897	0.00186	CcSEcCtD
Asenapine—Agranulocytosis—Doxorubicin—sarcoma	0.000891	0.00185	CcSEcCtD
Asenapine—Rash—Mitoxantrone—sarcoma	0.00089	0.00185	CcSEcCtD
Asenapine—Dermatitis—Mitoxantrone—sarcoma	0.000889	0.00185	CcSEcCtD
Asenapine—Headache—Mitoxantrone—sarcoma	0.000884	0.00184	CcSEcCtD
Asenapine—Eye disorder—Epirubicin—sarcoma	0.000865	0.0018	CcSEcCtD
Asenapine—Hypersensitivity—Etoposide—sarcoma	0.000865	0.0018	CcSEcCtD
Asenapine—Nausea—Vincristine—sarcoma	0.000861	0.00179	CcSEcCtD
Asenapine—Cardiac disorder—Epirubicin—sarcoma	0.000859	0.00179	CcSEcCtD
Asenapine—Oedema peripheral—Doxorubicin—sarcoma	0.000844	0.00175	CcSEcCtD
Asenapine—HTR2A—testis—sarcoma	0.000843	0.00254	CbGeAlD
Asenapine—Asthenia—Etoposide—sarcoma	0.000842	0.00175	CcSEcCtD
Asenapine—Connective tissue disorder—Doxorubicin—sarcoma	0.000842	0.00175	CcSEcCtD
Asenapine—Angiopathy—Epirubicin—sarcoma	0.00084	0.00175	CcSEcCtD
Asenapine—Nausea—Mitoxantrone—sarcoma	0.000838	0.00174	CcSEcCtD
Asenapine—Immune system disorder—Epirubicin—sarcoma	0.000836	0.00174	CcSEcCtD
Asenapine—Mediastinal disorder—Epirubicin—sarcoma	0.000835	0.00173	CcSEcCtD
Asenapine—Mental disorder—Epirubicin—sarcoma	0.000811	0.00169	CcSEcCtD
Asenapine—Malnutrition—Epirubicin—sarcoma	0.000806	0.00168	CcSEcCtD
Asenapine—Eye disorder—Doxorubicin—sarcoma	0.000801	0.00166	CcSEcCtD
Asenapine—HTR2A—liver—sarcoma	0.000797	0.0024	CbGeAlD
Asenapine—Cardiac disorder—Doxorubicin—sarcoma	0.000795	0.00165	CcSEcCtD
Asenapine—Dysgeusia—Epirubicin—sarcoma	0.000789	0.00164	CcSEcCtD
Asenapine—Angiopathy—Doxorubicin—sarcoma	0.000777	0.00162	CcSEcCtD
Asenapine—Dizziness—Etoposide—sarcoma	0.000776	0.00161	CcSEcCtD
Asenapine—Muscle spasms—Epirubicin—sarcoma	0.000775	0.00161	CcSEcCtD
Asenapine—Immune system disorder—Doxorubicin—sarcoma	0.000774	0.00161	CcSEcCtD
Asenapine—Mediastinal disorder—Doxorubicin—sarcoma	0.000772	0.0016	CcSEcCtD
Asenapine—CYP2D6—testis—sarcoma	0.000768	0.00231	CbGeAlD
Asenapine—Mental disorder—Doxorubicin—sarcoma	0.000751	0.00156	CcSEcCtD
Asenapine—Vomiting—Etoposide—sarcoma	0.000746	0.00155	CcSEcCtD
Asenapine—Malnutrition—Doxorubicin—sarcoma	0.000746	0.00155	CcSEcCtD
Asenapine—Anaemia—Epirubicin—sarcoma	0.000745	0.00155	CcSEcCtD
Asenapine—Agitation—Epirubicin—sarcoma	0.000741	0.00154	CcSEcCtD
Asenapine—Rash—Etoposide—sarcoma	0.00074	0.00154	CcSEcCtD
Asenapine—Dermatitis—Etoposide—sarcoma	0.000739	0.00154	CcSEcCtD
Asenapine—CYP3A4—liver—sarcoma	0.000738	0.00222	CbGeAlD
Asenapine—Headache—Etoposide—sarcoma	0.000735	0.00153	CcSEcCtD
Asenapine—HRH1—lymph node—sarcoma	0.000732	0.0022	CbGeAlD
Asenapine—Dysgeusia—Doxorubicin—sarcoma	0.00073	0.00152	CcSEcCtD
Asenapine—Malaise—Epirubicin—sarcoma	0.000727	0.00151	CcSEcCtD
Asenapine—CYP2D6—liver—sarcoma	0.000726	0.00218	CbGeAlD
Asenapine—Syncope—Epirubicin—sarcoma	0.000723	0.0015	CcSEcCtD
Asenapine—Leukopenia—Epirubicin—sarcoma	0.000722	0.0015	CcSEcCtD
Asenapine—ADRA2A—lymph node—sarcoma	0.000719	0.00216	CbGeAlD
Asenapine—Muscle spasms—Doxorubicin—sarcoma	0.000717	0.00149	CcSEcCtD
Asenapine—Loss of consciousness—Epirubicin—sarcoma	0.000708	0.00147	CcSEcCtD
Asenapine—Convulsion—Epirubicin—sarcoma	0.000698	0.00145	CcSEcCtD
Asenapine—Nausea—Etoposide—sarcoma	0.000697	0.00145	CcSEcCtD
Asenapine—Hypertension—Epirubicin—sarcoma	0.000696	0.00145	CcSEcCtD
Asenapine—Anaemia—Doxorubicin—sarcoma	0.000689	0.00143	CcSEcCtD
Asenapine—Arthralgia—Epirubicin—sarcoma	0.000686	0.00143	CcSEcCtD
Asenapine—Agitation—Doxorubicin—sarcoma	0.000685	0.00142	CcSEcCtD
Asenapine—Anxiety—Epirubicin—sarcoma	0.000684	0.00142	CcSEcCtD
Asenapine—Malaise—Doxorubicin—sarcoma	0.000673	0.0014	CcSEcCtD
Asenapine—Dry mouth—Epirubicin—sarcoma	0.000671	0.00139	CcSEcCtD
Asenapine—Syncope—Doxorubicin—sarcoma	0.000669	0.00139	CcSEcCtD
Asenapine—Leukopenia—Doxorubicin—sarcoma	0.000668	0.00139	CcSEcCtD
Asenapine—Anaphylactic shock—Epirubicin—sarcoma	0.000658	0.00137	CcSEcCtD
Asenapine—Loss of consciousness—Doxorubicin—sarcoma	0.000656	0.00136	CcSEcCtD
Asenapine—Shock—Epirubicin—sarcoma	0.000647	0.00134	CcSEcCtD
Asenapine—Convulsion—Doxorubicin—sarcoma	0.000646	0.00134	CcSEcCtD
Asenapine—Nervous system disorder—Epirubicin—sarcoma	0.000645	0.00134	CcSEcCtD
Asenapine—Thrombocytopenia—Epirubicin—sarcoma	0.000644	0.00134	CcSEcCtD
Asenapine—Hypertension—Doxorubicin—sarcoma	0.000644	0.00134	CcSEcCtD
Asenapine—Tachycardia—Epirubicin—sarcoma	0.000642	0.00133	CcSEcCtD
Asenapine—Arthralgia—Doxorubicin—sarcoma	0.000635	0.00132	CcSEcCtD
Asenapine—Anxiety—Doxorubicin—sarcoma	0.000633	0.00131	CcSEcCtD
Asenapine—Dry mouth—Doxorubicin—sarcoma	0.000621	0.00129	CcSEcCtD
Asenapine—Hypotension—Epirubicin—sarcoma	0.000615	0.00128	CcSEcCtD
Asenapine—Anaphylactic shock—Doxorubicin—sarcoma	0.000609	0.00126	CcSEcCtD
Asenapine—Musculoskeletal discomfort—Epirubicin—sarcoma	0.000599	0.00125	CcSEcCtD
Asenapine—Shock—Doxorubicin—sarcoma	0.000599	0.00124	CcSEcCtD
Asenapine—Nervous system disorder—Doxorubicin—sarcoma	0.000597	0.00124	CcSEcCtD
Asenapine—Thrombocytopenia—Doxorubicin—sarcoma	0.000596	0.00124	CcSEcCtD
Asenapine—Insomnia—Epirubicin—sarcoma	0.000595	0.00124	CcSEcCtD
Asenapine—Tachycardia—Doxorubicin—sarcoma	0.000594	0.00123	CcSEcCtD
Asenapine—Dyspnoea—Epirubicin—sarcoma	0.000587	0.00122	CcSEcCtD
Asenapine—Somnolence—Epirubicin—sarcoma	0.000585	0.00122	CcSEcCtD
Asenapine—Dyspepsia—Epirubicin—sarcoma	0.000579	0.0012	CcSEcCtD
Asenapine—Hypotension—Doxorubicin—sarcoma	0.000569	0.00118	CcSEcCtD
Asenapine—Gastrointestinal disorder—Epirubicin—sarcoma	0.000568	0.00118	CcSEcCtD
Asenapine—Fatigue—Epirubicin—sarcoma	0.000567	0.00118	CcSEcCtD
Asenapine—Constipation—Epirubicin—sarcoma	0.000563	0.00117	CcSEcCtD
Asenapine—Musculoskeletal discomfort—Doxorubicin—sarcoma	0.000555	0.00115	CcSEcCtD
Asenapine—Insomnia—Doxorubicin—sarcoma	0.000551	0.00114	CcSEcCtD
Asenapine—Dyspnoea—Doxorubicin—sarcoma	0.000543	0.00113	CcSEcCtD
Asenapine—Somnolence—Doxorubicin—sarcoma	0.000541	0.00112	CcSEcCtD
Asenapine—Dyspepsia—Doxorubicin—sarcoma	0.000536	0.00111	CcSEcCtD
Asenapine—Gastrointestinal disorder—Doxorubicin—sarcoma	0.000526	0.00109	CcSEcCtD
Asenapine—Fatigue—Doxorubicin—sarcoma	0.000525	0.00109	CcSEcCtD
Asenapine—Constipation—Doxorubicin—sarcoma	0.000521	0.00108	CcSEcCtD
Asenapine—Hypersensitivity—Epirubicin—sarcoma	0.000485	0.00101	CcSEcCtD
Asenapine—Asthenia—Epirubicin—sarcoma	0.000472	0.000981	CcSEcCtD
Asenapine—Hypersensitivity—Doxorubicin—sarcoma	0.000448	0.000932	CcSEcCtD
Asenapine—Asthenia—Doxorubicin—sarcoma	0.000437	0.000908	CcSEcCtD
Asenapine—Dizziness—Epirubicin—sarcoma	0.000435	0.000904	CcSEcCtD
Asenapine—Vomiting—Epirubicin—sarcoma	0.000418	0.000869	CcSEcCtD
Asenapine—Rash—Epirubicin—sarcoma	0.000415	0.000862	CcSEcCtD
Asenapine—Dermatitis—Epirubicin—sarcoma	0.000414	0.000861	CcSEcCtD
Asenapine—Headache—Epirubicin—sarcoma	0.000412	0.000856	CcSEcCtD
Asenapine—Dizziness—Doxorubicin—sarcoma	0.000403	0.000836	CcSEcCtD
Asenapine—Nausea—Epirubicin—sarcoma	0.000391	0.000812	CcSEcCtD
Asenapine—Vomiting—Doxorubicin—sarcoma	0.000387	0.000804	CcSEcCtD
Asenapine—Rash—Doxorubicin—sarcoma	0.000384	0.000798	CcSEcCtD
Asenapine—Dermatitis—Doxorubicin—sarcoma	0.000383	0.000797	CcSEcCtD
Asenapine—Headache—Doxorubicin—sarcoma	0.000381	0.000792	CcSEcCtD
Asenapine—Nausea—Doxorubicin—sarcoma	0.000362	0.000751	CcSEcCtD
Asenapine—HTR2B—Signaling Pathways—JUN—sarcoma	5.64e-06	0.000239	CbGpPWpGaD
Asenapine—DRD3—Signaling by GPCR—HRAS—sarcoma	5.61e-06	0.000238	CbGpPWpGaD
Asenapine—HTR2B—Signaling Pathways—CTNNB1—sarcoma	5.6e-06	0.000237	CbGpPWpGaD
Asenapine—DRD2—Signaling Pathways—CREB1—sarcoma	5.58e-06	0.000237	CbGpPWpGaD
Asenapine—ADRA2C—Signaling by GPCR—KRAS—sarcoma	5.56e-06	0.000236	CbGpPWpGaD
Asenapine—HTR6—Signaling Pathways—SRC—sarcoma	5.54e-06	0.000235	CbGpPWpGaD
Asenapine—HTR7—Signaling Pathways—SRC—sarcoma	5.54e-06	0.000235	CbGpPWpGaD
Asenapine—ADRB1—Signaling Pathways—MDM2—sarcoma	5.5e-06	0.000233	CbGpPWpGaD
Asenapine—HTR1D—Signaling Pathways—SRC—sarcoma	5.5e-06	0.000233	CbGpPWpGaD
Asenapine—HTR2A—Signaling Pathways—CREB1—sarcoma	5.49e-06	0.000233	CbGpPWpGaD
Asenapine—HRH1—Signaling Pathways—CREB1—sarcoma	5.48e-06	0.000233	CbGpPWpGaD
Asenapine—DRD1—Signaling Pathways—IL2—sarcoma	5.47e-06	0.000232	CbGpPWpGaD
Asenapine—ADRA2B—Signaling Pathways—MDM2—sarcoma	5.45e-06	0.000231	CbGpPWpGaD
Asenapine—HTR6—Signaling Pathways—VEGFA—sarcoma	5.4e-06	0.000229	CbGpPWpGaD
Asenapine—DRD3—Signaling Pathways—IL2—sarcoma	5.39e-06	0.000229	CbGpPWpGaD
Asenapine—HTR7—Signaling Pathways—VEGFA—sarcoma	5.39e-06	0.000229	CbGpPWpGaD
Asenapine—HTR1B—Signaling Pathways—SRC—sarcoma	5.39e-06	0.000228	CbGpPWpGaD
Asenapine—ADRB2—Signaling Pathways—MDM2—sarcoma	5.38e-06	0.000228	CbGpPWpGaD
Asenapine—ADRA1A—Signaling Pathways—CREB1—sarcoma	5.38e-06	0.000228	CbGpPWpGaD
Asenapine—HTR1D—Signaling Pathways—VEGFA—sarcoma	5.36e-06	0.000227	CbGpPWpGaD
Asenapine—DRD2—Signaling by GPCR—EGFR—sarcoma	5.34e-06	0.000227	CbGpPWpGaD
Asenapine—HTR6—Signaling Pathways—NRAS—sarcoma	5.33e-06	0.000226	CbGpPWpGaD
Asenapine—DRD1—Signaling Pathways—CCND1—sarcoma	5.33e-06	0.000226	CbGpPWpGaD
Asenapine—HTR7—Signaling Pathways—NRAS—sarcoma	5.33e-06	0.000226	CbGpPWpGaD
Asenapine—DRD1—Signaling Pathways—JUN—sarcoma	5.32e-06	0.000226	CbGpPWpGaD
Asenapine—HRH2—Signaling Pathways—TP53—sarcoma	5.32e-06	0.000226	CbGpPWpGaD
Asenapine—DRD4—Signaling Pathways—SRC—sarcoma	5.3e-06	0.000225	CbGpPWpGaD
Asenapine—HTR1D—Signaling Pathways—NRAS—sarcoma	5.29e-06	0.000224	CbGpPWpGaD
Asenapine—DRD1—Signaling Pathways—CTNNB1—sarcoma	5.28e-06	0.000224	CbGpPWpGaD
Asenapine—HTR1A—Signaling Pathways—MDM2—sarcoma	5.26e-06	0.000223	CbGpPWpGaD
Asenapine—DRD3—Signaling Pathways—CCND1—sarcoma	5.26e-06	0.000223	CbGpPWpGaD
Asenapine—HTR2A—Signaling by GPCR—EGFR—sarcoma	5.26e-06	0.000223	CbGpPWpGaD
Asenapine—ADRA2A—Signaling Pathways—KIT—sarcoma	5.25e-06	0.000223	CbGpPWpGaD
Asenapine—ADRA2A—Signaling by GPCR—NRAS—sarcoma	5.25e-06	0.000223	CbGpPWpGaD
Asenapine—DRD3—Signaling Pathways—JUN—sarcoma	5.25e-06	0.000223	CbGpPWpGaD
Asenapine—HRH1—Signaling by GPCR—EGFR—sarcoma	5.25e-06	0.000223	CbGpPWpGaD
Asenapine—HTR1B—Signaling Pathways—VEGFA—sarcoma	5.25e-06	0.000223	CbGpPWpGaD
Asenapine—HTR2C—Signaling Pathways—MDM2—sarcoma	5.23e-06	0.000222	CbGpPWpGaD
Asenapine—DRD3—Signaling Pathways—CTNNB1—sarcoma	5.21e-06	0.000221	CbGpPWpGaD
Asenapine—HTR1B—Signaling Pathways—NRAS—sarcoma	5.18e-06	0.00022	CbGpPWpGaD
Asenapine—DRD4—Signaling Pathways—VEGFA—sarcoma	5.16e-06	0.000219	CbGpPWpGaD
Asenapine—ADRA1A—Signaling by GPCR—EGFR—sarcoma	5.15e-06	0.000218	CbGpPWpGaD
Asenapine—ADRB1—Signaling by GPCR—HRAS—sarcoma	5.11e-06	0.000217	CbGpPWpGaD
Asenapine—DRD4—Signaling Pathways—NRAS—sarcoma	5.1e-06	0.000216	CbGpPWpGaD
Asenapine—ADRA2C—Signaling Pathways—MDM2—sarcoma	5.09e-06	0.000216	CbGpPWpGaD
Asenapine—HRH2—Signaling Pathways—HRAS—sarcoma	5.09e-06	0.000216	CbGpPWpGaD
Asenapine—ADRA2B—Signaling by GPCR—HRAS—sarcoma	5.06e-06	0.000215	CbGpPWpGaD
Asenapine—HTR2B—Signaling Pathways—SRC—sarcoma	5.06e-06	0.000215	CbGpPWpGaD
Asenapine—DRD2—Signaling by GPCR—KRAS—sarcoma	5.05e-06	0.000214	CbGpPWpGaD
Asenapine—ADRB2—Signaling by GPCR—HRAS—sarcoma	5e-06	0.000212	CbGpPWpGaD
Asenapine—ADRA2A—Signaling Pathways—CREB1—sarcoma	5e-06	0.000212	CbGpPWpGaD
Asenapine—HTR2A—Signaling by GPCR—KRAS—sarcoma	4.97e-06	0.000211	CbGpPWpGaD
Asenapine—HTR6—Signaling Pathways—MYC—sarcoma	4.97e-06	0.000211	CbGpPWpGaD
Asenapine—HTR7—Signaling Pathways—MYC—sarcoma	4.96e-06	0.00021	CbGpPWpGaD
Asenapine—HRH1—Signaling by GPCR—KRAS—sarcoma	4.96e-06	0.00021	CbGpPWpGaD
Asenapine—CYP3A4—Metabolism—PLCG1—sarcoma	4.95e-06	0.00021	CbGpPWpGaD
Asenapine—HTR1D—Signaling Pathways—MYC—sarcoma	4.93e-06	0.000209	CbGpPWpGaD
Asenapine—HTR2B—Signaling Pathways—VEGFA—sarcoma	4.93e-06	0.000209	CbGpPWpGaD
Asenapine—ADRB1—Signaling Pathways—IL2—sarcoma	4.92e-06	0.000209	CbGpPWpGaD
Asenapine—HTR1A—Signaling by GPCR—HRAS—sarcoma	4.89e-06	0.000207	CbGpPWpGaD
Asenapine—ADRA2B—Signaling Pathways—IL2—sarcoma	4.87e-06	0.000207	CbGpPWpGaD
Asenapine—HTR2B—Signaling Pathways—NRAS—sarcoma	4.87e-06	0.000206	CbGpPWpGaD
Asenapine—ADRA1A—Signaling by GPCR—KRAS—sarcoma	4.86e-06	0.000206	CbGpPWpGaD
Asenapine—HTR2C—Signaling by GPCR—HRAS—sarcoma	4.86e-06	0.000206	CbGpPWpGaD
Asenapine—HTR6—Signaling Pathways—EGFR—sarcoma	4.86e-06	0.000206	CbGpPWpGaD
Asenapine—HTR7—Signaling Pathways—EGFR—sarcoma	4.85e-06	0.000206	CbGpPWpGaD
Asenapine—HTR1B—Signaling Pathways—MYC—sarcoma	4.83e-06	0.000205	CbGpPWpGaD
Asenapine—HTR1D—Signaling Pathways—EGFR—sarcoma	4.82e-06	0.000205	CbGpPWpGaD
Asenapine—ADRB2—Signaling Pathways—IL2—sarcoma	4.81e-06	0.000204	CbGpPWpGaD
Asenapine—ADRB1—Signaling Pathways—CCND1—sarcoma	4.79e-06	0.000203	CbGpPWpGaD
Asenapine—ADRA2A—Signaling by GPCR—EGFR—sarcoma	4.78e-06	0.000203	CbGpPWpGaD
Asenapine—ADRB1—Signaling Pathways—JUN—sarcoma	4.78e-06	0.000203	CbGpPWpGaD
Asenapine—DRD1—Signaling Pathways—SRC—sarcoma	4.77e-06	0.000202	CbGpPWpGaD
Asenapine—DRD4—Signaling Pathways—MYC—sarcoma	4.75e-06	0.000201	CbGpPWpGaD
Asenapine—ADRA2B—Signaling Pathways—CCND1—sarcoma	4.75e-06	0.000201	CbGpPWpGaD
Asenapine—ADRB1—Signaling Pathways—CTNNB1—sarcoma	4.75e-06	0.000201	CbGpPWpGaD
Asenapine—ADRA2B—Signaling Pathways—JUN—sarcoma	4.74e-06	0.000201	CbGpPWpGaD
Asenapine—ADRA2C—Signaling by GPCR—HRAS—sarcoma	4.73e-06	0.000201	CbGpPWpGaD
Asenapine—HTR1B—Signaling Pathways—EGFR—sarcoma	4.72e-06	0.0002	CbGpPWpGaD
Asenapine—DRD3—Signaling Pathways—SRC—sarcoma	4.71e-06	0.0002	CbGpPWpGaD
Asenapine—ADRA2B—Signaling Pathways—CTNNB1—sarcoma	4.7e-06	0.000199	CbGpPWpGaD
Asenapine—HTR1A—Signaling Pathways—IL2—sarcoma	4.7e-06	0.000199	CbGpPWpGaD
Asenapine—ADRB2—Signaling Pathways—CCND1—sarcoma	4.69e-06	0.000199	CbGpPWpGaD
Asenapine—HTR2C—Signaling Pathways—IL2—sarcoma	4.68e-06	0.000198	CbGpPWpGaD
Asenapine—ADRB2—Signaling Pathways—JUN—sarcoma	4.68e-06	0.000198	CbGpPWpGaD
Asenapine—DRD1—Signaling Pathways—VEGFA—sarcoma	4.65e-06	0.000197	CbGpPWpGaD
Asenapine—DRD4—Signaling Pathways—EGFR—sarcoma	4.65e-06	0.000197	CbGpPWpGaD
Asenapine—ADRB2—Signaling Pathways—CTNNB1—sarcoma	4.64e-06	0.000197	CbGpPWpGaD
Asenapine—DRD2—Signaling Pathways—MDM2—sarcoma	4.62e-06	0.000196	CbGpPWpGaD
Asenapine—DRD1—Signaling Pathways—NRAS—sarcoma	4.59e-06	0.000195	CbGpPWpGaD
Asenapine—HTR6—Signaling Pathways—KRAS—sarcoma	4.59e-06	0.000195	CbGpPWpGaD
Asenapine—DRD3—Signaling Pathways—VEGFA—sarcoma	4.58e-06	0.000195	CbGpPWpGaD
Asenapine—HTR7—Signaling Pathways—KRAS—sarcoma	4.58e-06	0.000194	CbGpPWpGaD
Asenapine—HTR1A—Signaling Pathways—CCND1—sarcoma	4.58e-06	0.000194	CbGpPWpGaD
Asenapine—HTR1A—Signaling Pathways—JUN—sarcoma	4.57e-06	0.000194	CbGpPWpGaD
Asenapine—HTR2C—Signaling Pathways—CCND1—sarcoma	4.56e-06	0.000193	CbGpPWpGaD
Asenapine—HTR1D—Signaling Pathways—KRAS—sarcoma	4.55e-06	0.000193	CbGpPWpGaD
Asenapine—HTR2C—Signaling Pathways—JUN—sarcoma	4.55e-06	0.000193	CbGpPWpGaD
Asenapine—ADRA2C—Signaling Pathways—IL2—sarcoma	4.55e-06	0.000193	CbGpPWpGaD
Asenapine—HTR2A—Signaling Pathways—MDM2—sarcoma	4.55e-06	0.000193	CbGpPWpGaD
Asenapine—HTR1A—Signaling Pathways—CTNNB1—sarcoma	4.54e-06	0.000193	CbGpPWpGaD
Asenapine—HRH1—Signaling Pathways—MDM2—sarcoma	4.54e-06	0.000192	CbGpPWpGaD
Asenapine—HTR2B—Signaling Pathways—MYC—sarcoma	4.53e-06	0.000192	CbGpPWpGaD
Asenapine—DRD3—Signaling Pathways—NRAS—sarcoma	4.53e-06	0.000192	CbGpPWpGaD
Asenapine—ADRA2A—Signaling by GPCR—KRAS—sarcoma	4.52e-06	0.000192	CbGpPWpGaD
Asenapine—HTR2C—Signaling Pathways—CTNNB1—sarcoma	4.52e-06	0.000192	CbGpPWpGaD
Asenapine—HTR1B—Signaling Pathways—KRAS—sarcoma	4.46e-06	0.000189	CbGpPWpGaD
Asenapine—ADRA1A—Signaling Pathways—MDM2—sarcoma	4.45e-06	0.000189	CbGpPWpGaD
Asenapine—ADRA2C—Signaling Pathways—CCND1—sarcoma	4.44e-06	0.000188	CbGpPWpGaD
Asenapine—HTR2B—Signaling Pathways—EGFR—sarcoma	4.43e-06	0.000188	CbGpPWpGaD
Asenapine—ADRA2C—Signaling Pathways—JUN—sarcoma	4.43e-06	0.000188	CbGpPWpGaD
Asenapine—ADRA2C—Signaling Pathways—CTNNB1—sarcoma	4.39e-06	0.000186	CbGpPWpGaD
Asenapine—DRD4—Signaling Pathways—KRAS—sarcoma	4.39e-06	0.000186	CbGpPWpGaD
Asenapine—DRD2—Signaling by GPCR—HRAS—sarcoma	4.29e-06	0.000182	CbGpPWpGaD
Asenapine—ADRB1—Signaling Pathways—SRC—sarcoma	4.29e-06	0.000182	CbGpPWpGaD
Asenapine—DRD1—Signaling Pathways—MYC—sarcoma	4.28e-06	0.000181	CbGpPWpGaD
Asenapine—ADRA2B—Signaling Pathways—SRC—sarcoma	4.25e-06	0.00018	CbGpPWpGaD
Asenapine—HTR2A—Signaling by GPCR—HRAS—sarcoma	4.22e-06	0.000179	CbGpPWpGaD
Asenapine—DRD3—Signaling Pathways—MYC—sarcoma	4.22e-06	0.000179	CbGpPWpGaD
Asenapine—HRH1—Signaling by GPCR—HRAS—sarcoma	4.21e-06	0.000179	CbGpPWpGaD
Asenapine—ADRB2—Signaling Pathways—SRC—sarcoma	4.2e-06	0.000178	CbGpPWpGaD
Asenapine—HTR2B—Signaling Pathways—KRAS—sarcoma	4.19e-06	0.000178	CbGpPWpGaD
Asenapine—DRD1—Signaling Pathways—EGFR—sarcoma	4.18e-06	0.000177	CbGpPWpGaD
Asenapine—ADRB1—Signaling Pathways—VEGFA—sarcoma	4.18e-06	0.000177	CbGpPWpGaD
Asenapine—ADRA2B—Signaling Pathways—VEGFA—sarcoma	4.14e-06	0.000176	CbGpPWpGaD
Asenapine—ADRA2A—Signaling Pathways—MDM2—sarcoma	4.14e-06	0.000175	CbGpPWpGaD
Asenapine—ADRA1A—Signaling by GPCR—HRAS—sarcoma	4.13e-06	0.000175	CbGpPWpGaD
Asenapine—DRD2—Signaling Pathways—IL2—sarcoma	4.13e-06	0.000175	CbGpPWpGaD
Asenapine—ADRB1—Signaling Pathways—NRAS—sarcoma	4.13e-06	0.000175	CbGpPWpGaD
Asenapine—DRD3—Signaling Pathways—EGFR—sarcoma	4.13e-06	0.000175	CbGpPWpGaD
Asenapine—HTR1A—Signaling Pathways—SRC—sarcoma	4.1e-06	0.000174	CbGpPWpGaD
Asenapine—ADRA2B—Signaling Pathways—NRAS—sarcoma	4.09e-06	0.000173	CbGpPWpGaD
Asenapine—ADRB2—Signaling Pathways—VEGFA—sarcoma	4.09e-06	0.000173	CbGpPWpGaD
Asenapine—HTR2C—Signaling Pathways—SRC—sarcoma	4.08e-06	0.000173	CbGpPWpGaD
Asenapine—HTR6—Signaling Pathways—TP53—sarcoma	4.08e-06	0.000173	CbGpPWpGaD
Asenapine—HTR7—Signaling Pathways—TP53—sarcoma	4.07e-06	0.000173	CbGpPWpGaD
Asenapine—HTR2A—Signaling Pathways—IL2—sarcoma	4.06e-06	0.000172	CbGpPWpGaD
Asenapine—HRH1—Signaling Pathways—IL2—sarcoma	4.05e-06	0.000172	CbGpPWpGaD
Asenapine—HTR1D—Signaling Pathways—TP53—sarcoma	4.05e-06	0.000172	CbGpPWpGaD
Asenapine—ADRB2—Signaling Pathways—NRAS—sarcoma	4.04e-06	0.000171	CbGpPWpGaD
Asenapine—DRD2—Signaling Pathways—CCND1—sarcoma	4.02e-06	0.000171	CbGpPWpGaD
Asenapine—DRD2—Signaling Pathways—JUN—sarcoma	4.02e-06	0.00017	CbGpPWpGaD
Asenapine—HTR1A—Signaling Pathways—VEGFA—sarcoma	4e-06	0.00017	CbGpPWpGaD
Asenapine—DRD2—Signaling Pathways—CTNNB1—sarcoma	3.99e-06	0.000169	CbGpPWpGaD
Asenapine—ADRA1A—Signaling Pathways—IL2—sarcoma	3.98e-06	0.000169	CbGpPWpGaD
Asenapine—HTR2C—Signaling Pathways—VEGFA—sarcoma	3.98e-06	0.000169	CbGpPWpGaD
Asenapine—ADRA2C—Signaling Pathways—SRC—sarcoma	3.97e-06	0.000168	CbGpPWpGaD
Asenapine—HTR1B—Signaling Pathways—TP53—sarcoma	3.96e-06	0.000168	CbGpPWpGaD
Asenapine—HTR2A—Signaling Pathways—CCND1—sarcoma	3.96e-06	0.000168	CbGpPWpGaD
Asenapine—HTR2A—Signaling Pathways—JUN—sarcoma	3.95e-06	0.000168	CbGpPWpGaD
Asenapine—HRH1—Signaling Pathways—CCND1—sarcoma	3.95e-06	0.000168	CbGpPWpGaD
Asenapine—DRD1—Signaling Pathways—KRAS—sarcoma	3.95e-06	0.000168	CbGpPWpGaD
Asenapine—HTR1A—Signaling Pathways—NRAS—sarcoma	3.95e-06	0.000167	CbGpPWpGaD
Asenapine—HRH1—Signaling Pathways—JUN—sarcoma	3.94e-06	0.000167	CbGpPWpGaD
Asenapine—HTR2C—Signaling Pathways—NRAS—sarcoma	3.93e-06	0.000167	CbGpPWpGaD
Asenapine—HTR2A—Signaling Pathways—CTNNB1—sarcoma	3.92e-06	0.000166	CbGpPWpGaD
Asenapine—HRH1—Signaling Pathways—CTNNB1—sarcoma	3.91e-06	0.000166	CbGpPWpGaD
Asenapine—HTR6—Signaling Pathways—HRAS—sarcoma	3.9e-06	0.000165	CbGpPWpGaD
Asenapine—DRD4—Signaling Pathways—TP53—sarcoma	3.9e-06	0.000165	CbGpPWpGaD
Asenapine—DRD3—Signaling Pathways—KRAS—sarcoma	3.9e-06	0.000165	CbGpPWpGaD
Asenapine—HTR7—Signaling Pathways—HRAS—sarcoma	3.9e-06	0.000165	CbGpPWpGaD
Asenapine—ADRA1A—Signaling Pathways—CCND1—sarcoma	3.88e-06	0.000164	CbGpPWpGaD
Asenapine—HTR1D—Signaling Pathways—HRAS—sarcoma	3.87e-06	0.000164	CbGpPWpGaD
Asenapine—ADRA1A—Signaling Pathways—JUN—sarcoma	3.87e-06	0.000164	CbGpPWpGaD
Asenapine—ADRA2C—Signaling Pathways—VEGFA—sarcoma	3.87e-06	0.000164	CbGpPWpGaD
Asenapine—ADRB1—Signaling Pathways—MYC—sarcoma	3.84e-06	0.000163	CbGpPWpGaD
Asenapine—ADRA2A—Signaling by GPCR—HRAS—sarcoma	3.84e-06	0.000163	CbGpPWpGaD
Asenapine—ADRA1A—Signaling Pathways—CTNNB1—sarcoma	3.84e-06	0.000163	CbGpPWpGaD
Asenapine—ADRA2C—Signaling Pathways—NRAS—sarcoma	3.82e-06	0.000162	CbGpPWpGaD
Asenapine—ADRA2B—Signaling Pathways—MYC—sarcoma	3.81e-06	0.000162	CbGpPWpGaD
Asenapine—HTR1B—Signaling Pathways—HRAS—sarcoma	3.79e-06	0.000161	CbGpPWpGaD
Asenapine—ADRB2—Signaling Pathways—MYC—sarcoma	3.76e-06	0.00016	CbGpPWpGaD
Asenapine—ADRB1—Signaling Pathways—EGFR—sarcoma	3.76e-06	0.000159	CbGpPWpGaD
Asenapine—DRD4—Signaling Pathways—HRAS—sarcoma	3.73e-06	0.000158	CbGpPWpGaD
Asenapine—ADRA2B—Signaling Pathways—EGFR—sarcoma	3.73e-06	0.000158	CbGpPWpGaD
Asenapine—HTR2B—Signaling Pathways—TP53—sarcoma	3.72e-06	0.000158	CbGpPWpGaD
Asenapine—ADRA2A—Signaling Pathways—IL2—sarcoma	3.7e-06	0.000157	CbGpPWpGaD
Asenapine—ADRB2—Signaling Pathways—EGFR—sarcoma	3.68e-06	0.000156	CbGpPWpGaD
Asenapine—HTR1A—Signaling Pathways—MYC—sarcoma	3.68e-06	0.000156	CbGpPWpGaD
Asenapine—HTR2C—Signaling Pathways—MYC—sarcoma	3.66e-06	0.000155	CbGpPWpGaD
Asenapine—ADRA2A—Signaling Pathways—CCND1—sarcoma	3.6e-06	0.000153	CbGpPWpGaD
Asenapine—DRD2—Signaling Pathways—SRC—sarcoma	3.6e-06	0.000153	CbGpPWpGaD
Asenapine—HTR1A—Signaling Pathways—EGFR—sarcoma	3.6e-06	0.000153	CbGpPWpGaD
Asenapine—ADRA2A—Signaling Pathways—JUN—sarcoma	3.59e-06	0.000153	CbGpPWpGaD
Asenapine—HTR2C—Signaling Pathways—EGFR—sarcoma	3.58e-06	0.000152	CbGpPWpGaD
Asenapine—ADRA2A—Signaling Pathways—CTNNB1—sarcoma	3.57e-06	0.000151	CbGpPWpGaD
Asenapine—HTR2B—Signaling Pathways—HRAS—sarcoma	3.56e-06	0.000151	CbGpPWpGaD
Asenapine—ADRA2C—Signaling Pathways—MYC—sarcoma	3.56e-06	0.000151	CbGpPWpGaD
Asenapine—ADRB1—Signaling Pathways—KRAS—sarcoma	3.55e-06	0.000151	CbGpPWpGaD
Asenapine—HTR2A—Signaling Pathways—SRC—sarcoma	3.54e-06	0.00015	CbGpPWpGaD
Asenapine—HRH1—Signaling Pathways—SRC—sarcoma	3.54e-06	0.00015	CbGpPWpGaD
Asenapine—ADRA2B—Signaling Pathways—KRAS—sarcoma	3.52e-06	0.000149	CbGpPWpGaD
Asenapine—DRD1—Signaling Pathways—TP53—sarcoma	3.51e-06	0.000149	CbGpPWpGaD
Asenapine—DRD2—Signaling Pathways—VEGFA—sarcoma	3.51e-06	0.000149	CbGpPWpGaD
Asenapine—ADRA2C—Signaling Pathways—EGFR—sarcoma	3.48e-06	0.000148	CbGpPWpGaD
Asenapine—ADRB2—Signaling Pathways—KRAS—sarcoma	3.47e-06	0.000147	CbGpPWpGaD
Asenapine—ADRA1A—Signaling Pathways—SRC—sarcoma	3.47e-06	0.000147	CbGpPWpGaD
Asenapine—DRD2—Signaling Pathways—NRAS—sarcoma	3.47e-06	0.000147	CbGpPWpGaD
Asenapine—DRD3—Signaling Pathways—TP53—sarcoma	3.46e-06	0.000147	CbGpPWpGaD
Asenapine—HTR2A—Signaling Pathways—VEGFA—sarcoma	3.45e-06	0.000146	CbGpPWpGaD
Asenapine—HRH1—Signaling Pathways—VEGFA—sarcoma	3.44e-06	0.000146	CbGpPWpGaD
Asenapine—HTR2A—Signaling Pathways—NRAS—sarcoma	3.41e-06	0.000145	CbGpPWpGaD
Asenapine—HRH1—Signaling Pathways—NRAS—sarcoma	3.4e-06	0.000144	CbGpPWpGaD
Asenapine—HTR1A—Signaling Pathways—KRAS—sarcoma	3.4e-06	0.000144	CbGpPWpGaD
Asenapine—ADRA1A—Signaling Pathways—VEGFA—sarcoma	3.38e-06	0.000143	CbGpPWpGaD
Asenapine—HTR2C—Signaling Pathways—KRAS—sarcoma	3.38e-06	0.000143	CbGpPWpGaD
Asenapine—DRD1—Signaling Pathways—HRAS—sarcoma	3.36e-06	0.000142	CbGpPWpGaD
Asenapine—ADRA1A—Signaling Pathways—NRAS—sarcoma	3.34e-06	0.000142	CbGpPWpGaD
Asenapine—DRD3—Signaling Pathways—HRAS—sarcoma	3.31e-06	0.000141	CbGpPWpGaD
Asenapine—ADRA2C—Signaling Pathways—KRAS—sarcoma	3.29e-06	0.000139	CbGpPWpGaD
Asenapine—DRD2—Signaling Pathways—MYC—sarcoma	3.23e-06	0.000137	CbGpPWpGaD
Asenapine—ADRA2A—Signaling Pathways—SRC—sarcoma	3.22e-06	0.000137	CbGpPWpGaD
Asenapine—HTR2A—Signaling Pathways—MYC—sarcoma	3.18e-06	0.000135	CbGpPWpGaD
Asenapine—HRH1—Signaling Pathways—MYC—sarcoma	3.17e-06	0.000134	CbGpPWpGaD
Asenapine—DRD2—Signaling Pathways—EGFR—sarcoma	3.16e-06	0.000134	CbGpPWpGaD
Asenapine—ADRB1—Signaling Pathways—TP53—sarcoma	3.16e-06	0.000134	CbGpPWpGaD
Asenapine—ADRA2A—Signaling Pathways—VEGFA—sarcoma	3.14e-06	0.000133	CbGpPWpGaD
Asenapine—ADRA2B—Signaling Pathways—TP53—sarcoma	3.13e-06	0.000133	CbGpPWpGaD
Asenapine—ADRA1A—Signaling Pathways—MYC—sarcoma	3.11e-06	0.000132	CbGpPWpGaD
Asenapine—HTR2A—Signaling Pathways—EGFR—sarcoma	3.11e-06	0.000132	CbGpPWpGaD
Asenapine—ADRA2A—Signaling Pathways—NRAS—sarcoma	3.1e-06	0.000132	CbGpPWpGaD
Asenapine—HRH1—Signaling Pathways—EGFR—sarcoma	3.1e-06	0.000132	CbGpPWpGaD
Asenapine—ADRB2—Signaling Pathways—TP53—sarcoma	3.09e-06	0.000131	CbGpPWpGaD
Asenapine—ADRA1A—Signaling Pathways—EGFR—sarcoma	3.04e-06	0.000129	CbGpPWpGaD
Asenapine—HTR1A—Signaling Pathways—TP53—sarcoma	3.02e-06	0.000128	CbGpPWpGaD
Asenapine—ADRB1—Signaling Pathways—HRAS—sarcoma	3.02e-06	0.000128	CbGpPWpGaD
Asenapine—HTR2C—Signaling Pathways—TP53—sarcoma	3e-06	0.000127	CbGpPWpGaD
Asenapine—ADRA2B—Signaling Pathways—HRAS—sarcoma	2.99e-06	0.000127	CbGpPWpGaD
Asenapine—DRD2—Signaling Pathways—KRAS—sarcoma	2.98e-06	0.000127	CbGpPWpGaD
Asenapine—ADRB2—Signaling Pathways—HRAS—sarcoma	2.95e-06	0.000125	CbGpPWpGaD
Asenapine—HTR2A—Signaling Pathways—KRAS—sarcoma	2.93e-06	0.000125	CbGpPWpGaD
Asenapine—HRH1—Signaling Pathways—KRAS—sarcoma	2.93e-06	0.000124	CbGpPWpGaD
Asenapine—ADRA2C—Signaling Pathways—TP53—sarcoma	2.92e-06	0.000124	CbGpPWpGaD
Asenapine—ADRA2A—Signaling Pathways—MYC—sarcoma	2.89e-06	0.000123	CbGpPWpGaD
Asenapine—HTR1A—Signaling Pathways—HRAS—sarcoma	2.89e-06	0.000122	CbGpPWpGaD
Asenapine—ADRA1A—Signaling Pathways—KRAS—sarcoma	2.87e-06	0.000122	CbGpPWpGaD
Asenapine—HTR2C—Signaling Pathways—HRAS—sarcoma	2.87e-06	0.000122	CbGpPWpGaD
Asenapine—ADRA2A—Signaling Pathways—EGFR—sarcoma	2.83e-06	0.00012	CbGpPWpGaD
Asenapine—ADRA2C—Signaling Pathways—HRAS—sarcoma	2.79e-06	0.000119	CbGpPWpGaD
Asenapine—ADRA2A—Signaling Pathways—KRAS—sarcoma	2.67e-06	0.000113	CbGpPWpGaD
Asenapine—DRD2—Signaling Pathways—TP53—sarcoma	2.65e-06	0.000112	CbGpPWpGaD
Asenapine—HTR2A—Signaling Pathways—TP53—sarcoma	2.61e-06	0.000111	CbGpPWpGaD
Asenapine—HRH1—Signaling Pathways—TP53—sarcoma	2.6e-06	0.00011	CbGpPWpGaD
Asenapine—ADRA1A—Signaling Pathways—TP53—sarcoma	2.55e-06	0.000108	CbGpPWpGaD
Asenapine—DRD2—Signaling Pathways—HRAS—sarcoma	2.54e-06	0.000108	CbGpPWpGaD
Asenapine—HTR2A—Signaling Pathways—HRAS—sarcoma	2.49e-06	0.000106	CbGpPWpGaD
Asenapine—HRH1—Signaling Pathways—HRAS—sarcoma	2.49e-06	0.000106	CbGpPWpGaD
Asenapine—ADRA1A—Signaling Pathways—HRAS—sarcoma	2.44e-06	0.000104	CbGpPWpGaD
Asenapine—ADRA2A—Signaling Pathways—TP53—sarcoma	2.37e-06	0.000101	CbGpPWpGaD
Asenapine—ADRA2A—Signaling Pathways—HRAS—sarcoma	2.27e-06	9.63e-05	CbGpPWpGaD
